Glomerular disease: Eculizumab for the treatment of MPGN

Comment

Susan J Allison. Nat Rev Nephrol. 2012.

. 2012 Apr 10;8(6):314.

doi: 10.1038/nrneph.2012.72.

No abstract available

Comment on

Eculizumab in a patient with dense-deposit disease.
Daina E, Noris M, Remuzzi G. Daina E, et al. N Engl J Med. 2012 Mar 22;366(12):1161-3. doi: 10.1056/NEJMc1112273. N Engl J Med. 2012. PMID: 22435382 No abstract available.
Eculizumab for the treatment of dense-deposit disease.
Vivarelli M, Pasini A, Emma F. Vivarelli M, et al. N Engl J Med. 2012 Mar 22;366(12):1163-5. doi: 10.1056/NEJMc1111953. N Engl J Med. 2012. PMID: 22435383 No abstract available.
Eculizumab and refractory membranoproliferative glomerulonephritis.
Radhakrishnan S, Lunn A, Kirschfink M, Thorner P, Hebert D, Langlois V, Pluthero F, Licht C. Radhakrishnan S, et al. N Engl J Med. 2012 Mar 22;366(12):1165-6. doi: 10.1056/NEJMc1106619. N Engl J Med. 2012. PMID: 22435384 No abstract available.